Cholera PaxVax announced the availability of Vaxchora (oral cholera vaccine, live), the first vaccine for protection against cholera. PaxVax announced the availability of Vaxchora (oral cholera ...
The U.S. Food and Drug Administration today approved Vaxchora, a vaccine for the prevention of cholera caused by serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas.
The U.S. Department of Commerce has approved a broad ‌launch of OpenAI's advanced GPT 5.6 model, Axios reported on Tuesday, citing a person familiar with the matter. Reuters, the news and media ...
TORONTO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bavarian Nordic, a leading global supplier of travel vaccines, today announced the commercial availability of VAXCHORA ® —the only single-dose oral vaccine ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--PaxVax Inc., a fully integrated specialty vaccine company committed to developing and commercializing innovative vaccines against infectious diseases, today ...
Please provide your email address to receive an email when new articles are posted on . The FDA today approved Vaxchora as a vaccine for preventing cholera for travelers, according to a press release ...
Privately held PaxVax is getting a boost for its cholera vaccine with the U.S. Centers for Disease Control and Prevention now recommending Vaxchora for adults aged 18 to 64 traveling to areas where ...
GAITHERSBURG, Md., Jan. 31, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
Emergent Travel Health will temporarily discontinue the manufacture and distribution of Vaxchora and Vivotif in the US due to a significant reduction in international travel due to the COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results